ArticleInternational journal of radiation oncology, biology, physics2021

Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade.

Casey Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.